OSAM
BDTX icon

O'Shaughnessy Asset Management’s Black Diamond Therapeutics BDTX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$388K Sell
182,236
-172,218
-49% -$410K ﹤0.01% 1653
2025
Q4 		$861K Buy
354,454
+212,015
+149% +$751K ﹤0.01% 1218
2025
Q3 		$540K Buy
+142,439
New +$417K ﹤0.01% 1441

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

O'Shaughnessy Asset Management's BDTX Position: Q1 2026 in Review

O'Shaughnessy Asset Management reduced its Black Diamond Therapeutics (BDTX) stake by 49% in Q1 2026, selling an estimated $410K and leaving 182,236 shares worth $388K. The position accounts for ﹤0.01% of the portfolio, ranked #1653.

O'Shaughnessy Asset Management first reported a position in BDTX in Q3 2025 and has held it in 3 quarters since. The position peaked at $861K in Q4 2025. 104 funds tracked by Wall St. Rank hold BDTX as of Q1 2026.

  • O'Shaughnessy Asset Management held 182,236 shares of Black Diamond Therapeutics worth $388K as of Q1 2026.
  • O'Shaughnessy Asset Management sold 172,218 Black Diamond Therapeutics shares in Q1 2026, an estimated $410K.
  • Black Diamond Therapeutics made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #1653 holding.
  • O'Shaughnessy Asset Management first reported a position in Black Diamond Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • O'Shaughnessy Asset Management's Black Diamond Therapeutics position peaked at $861K in Q4 2025.
  • 104 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q1 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.